Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-administration of Zydus MR Vaccine and Yellow Fever Vaccine in Infants
NCT06815835Phase 3Not yet recruiting
- Sponsor
- icddr,b
- Start
- Apr 2025
- Primary completion
- Mar 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Measles rubella vaccine in measles, rubella, sponsored by icddr,b. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
Measles rubella vaccine
03
Conditions
measlesrubella
Beyond the preview
Go deeper on NCT06815835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06815835.